CollPlant Biotechnologies Balance Sheet Health
Financial Health criteria checks 5/6
CollPlant Biotechnologies has a total shareholder equity of $20.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $26.6M and $5.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$18.92m |
| Equity | US$20.73m |
| Total liabilities | US$5.84m |
| Total assets | US$26.57m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CPT's short term assets ($20.3M) exceed its short term liabilities ($3.2M).
Long Term Liabilities: CPT's short term assets ($20.3M) exceed its long term liabilities ($2.6M).
Debt to Equity History and Analysis
Debt Level: CPT is debt free.
Reducing Debt: CPT has no debt compared to 5 years ago when its debt to equity ratio was 2%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CPT has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if CPT has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.